389 related articles for article (PubMed ID: 6580499)
1. Mechanism of glucocorticoid action on murine natural killer cell activity.
Cox WI; Holbrook NJ; Friedman H
J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
Wright SC; Bonavida B
J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
[TBL] [Abstract][Full Text] [Related]
5. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon.
Holbrook NJ; Cox WI; Horner HC
Cancer Res; 1983 Sep; 43(9):4019-25. PubMed ID: 6871844
[TBL] [Abstract][Full Text] [Related]
6. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
7. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
8. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
9. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
Kiyohara T; Dennis JW; Boegman RJ; Roder JC
J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114
[TBL] [Abstract][Full Text] [Related]
10. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells.
Wayner EA; Brooks CG
J Immunol; 1984 Apr; 132(4):2135-42. PubMed ID: 6230401
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
Sharma BS; Mhaskar S; Balazs L; Siaw M
Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the activity of mouse natural killer cells by urethan.
Gorelik E; Herberman RB
J Natl Cancer Inst; 1981 Mar; 66(3):543-8. PubMed ID: 6937709
[TBL] [Abstract][Full Text] [Related]
13. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
Kalland T; Forsberg JG
J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
15. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and morphologic profile of endogenous and pyrimidinone-activated murine NK cells.
Lotzová E; Savary CA; Lowlachi M; Murasko DM
J Immunol; 1986 Jan; 136(2):732-40. PubMed ID: 2416824
[TBL] [Abstract][Full Text] [Related]
17. Renewal of natural killer cells in mice having elevated natural killer cell activity.
Nassiry L; Miller SC
Nat Immun Cell Growth Regul; 1987; 6(5):250-9. PubMed ID: 3444438
[TBL] [Abstract][Full Text] [Related]
18. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
Lotzová E; Savary CA; Stringfellow DA
J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
[TBL] [Abstract][Full Text] [Related]
19. Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells.
Saxena RK; Saxena QB; Adler WH
J Immunol; 1988 Sep; 141(5):1782-7. PubMed ID: 2457628
[TBL] [Abstract][Full Text] [Related]
20. Human natural killer-like activity against mouse spleen cells.
Yamamoto JK; Blalock JE; Johnson HM
Eur J Immunol; 1982 Mar; 12(3):222-7. PubMed ID: 7047174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
